Table 5.
SF-36v2 | Phototherapy | Controls | p |
---|---|---|---|
Physical Functioning | |||
Enrolment (n = 8, 9) | 97.5 (70–100) | 100 (80–100) | |
Six months (n = 9, 7) | 100 (80–100) | 100 (85–100) | 1.00 |
Twelve months (n = 8, 8) | 97.5 (75–100) | 97.5 (75–100) | 0.93 |
Role Physical | |||
Enrolment (n = 9, 8) | 100 (75–100) | 93.75 (37.5–100) | |
Six months (n = 9, 7) | 100 (81.25–100) | 93.75 (56.25–100) | 0.59 |
Twelve months (n = 8, 8) | 100 (56.25–100) | 90.63 (68.75–100) | 0.50 |
Bodily Pain | |||
Enrolment (n = 8, 9) | 100 (74–100) | 100 (62–100) | |
Six months (n = 9, 7) | 84 (51–100) | 84 (62–100) | 0.64 |
Twelve months (n = 8, 8) | 84 (62–100) | 84 (62–100) | 0.92 |
General Health | |||
Enrolment (n = 8, 9) | 74.5 (25–92) | 77 (57–97) | |
Six months (n = 9, 7) | 77 (37–100) | 72 (67–97) | 0.81 |
Twelve months (n = 8, 8) | 77 (35–100) | 74.5 (52–100) | 1.00 |
Vitality | |||
Enrolment (n = 8, 9) | 62.5 (12.5–87.5) | 75 (18.75–87) | |
Six months (n = 9, 7) | 75 (37.5–93.75) | 68.75 (31.25–75) | 0.42 |
Twelve months (n = 8, 8) | 71.88 (37.5–87.5) | 56.13 (43.75–75) | 0.26 |
Social Functioning | |||
Enrolment (n = 8, 9) | 93.75 (75–100) | 100 (50–100) | |
Six months (n = 9, 7) | 100 (75–100) | 87.5 (50–100) | 0.03 |
Twelve months (n = 8, 8) | 93.75 (75–100) | 87.5 (75–100) | 1.00 |
Role Emotional | |||
Enrolment (n = 8, 9) | 100 (75–100) | 100 (33.3–100) | |
Six months (n = 9, 7) | 91.67 (66.67–100) | 100 (33.3–100) | 0.65 |
Twelve months (n = 8, 8) | 100 (50–100) | 100 (75–100) | 0.87 |
Mental Health | |||
Enrolment (n = 8, 9) | 75 (45–100) | 85 (55–90) | |
Six months (n = 9, 7) | 80 (70–90) | 85 (60–95) | 0.99 |
Twelve months (n = 8, 8) | 85 (65–100) | 82.5 (60–95) | 0.52 |